Stocks and Investing Stocks and Investing
Wed, October 7, 2015
Tue, October 6, 2015
Mon, October 5, 2015

Matthew Harrison Upgraded (BLUE) to Buy and Held Target at $143 on, Oct 5th, 2015


Published on 2024-10-25 10:09:11 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Upgraded "bluebird bio, Inc." (BLUE) to Buy and Held Target at $143 on, Oct 5th, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy and Held Target at $190 on, Wednesday, June 17th, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $244 on, Monday, June 15th, 2015
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $239 on, Monday, June 15th, 2015
Contributing Sources